Management of cancer treatment-induced bone loss (CTIBL) in patients with breast cancer or prostate cancer
Crossref DOI link: https://doi.org/10.1007/s00774-023-01414-1
Published Online: 2023-04-10
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takahashi, Shunji http://orcid.org/0000-0002-5031-1953
Text and Data Mining valid from 2023-04-10
Version of Record valid from 2023-04-10
Article History
Received: 30 November 2022
Accepted: 27 February 2023
First Online: 10 April 2023
Declarations
:
: The author declares no conflicts of interest.